09939 KINTOR PHARMA-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.03X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 6.8% | Net Margin | N/A |
| Total Debt/Equity | 45.2% | Return on Equity | N/A |
| Price/Book | 3.55X | Return on Assets | N/A |
| (HKD 2.480) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -165.15 | -1,169.24 | -1,070.04 | -1,029.97 | -603.25 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +85.9 | -9.3 | -3.9 | -70.7 | -132.0 |
| Earnings Per Share (HKD) | -0.383 | -2.725 | -2.842 | -2.89 | -1.95 |
| Earnings Per Share Growth (%) | +85.9 | +4.1 | +1.7 | -48.2 | +100.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.699 | 1.128 | 3.746 | 5.223 | 4.845 |
| Auditors' Opinion | Unqualified # | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 5 | 0 | N/A | 0 |
| Operating Result | -156.365 | -1,069 | -85.4 | -952.096 |
| Associates | -1.429 | 0.052 | -2,848.1 | -0.568 |
| Profit Before Taxation | -155.274 | -1,069 | -85.5 | -953.284 |
| Taxation | 0.018 | -8.041 | -100.2 | 1.085 |
| Profit /( Loss) After Taxation | -155.292 | -1,061 | -85.4 | -954.369 |
| Net Profit | -155.292 | -1,061 | -85.4 | -954.369 |
| Earnings Per Share () | -0.3834 | -2.7251 | -85.9 | -2.8416 |
| Announcement Date | 2025-03-26 | 2024-03-28 | NA | 2023-03-30 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
